In addition to genes increasing the risk of CRC, we also report PGVs not typically associated with increased risk of CRC in 7.1% of eoCRC patients, including ATM, BRCA1, PALB2, SDHA, and MITF. This evidence concerns the gene PALB2 and colorectal carcinoma.